This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome

This study has been withdrawn prior to enrollment.
(The FDA IND application is paused due to additional required testing. The IRB protocol was closed prior to research starting.)
Sponsor:
Information provided by (Responsible Party):
Sean Mackey, Stanford University
ClinicalTrials.gov Identifier:
NCT00855972
First received: March 3, 2009
Last updated: December 9, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2011
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)